Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now later-stage tilt small index

Partial Epilepsy: later-stage trial registry

3 of 8 indexed Partial Epilepsy trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Partial Epilepsy: 8 US clinical trials tracked, 3 recruiting.

Partial Epilepsy is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Neurological Disorders and Stroke (NINDS), running 5 of these trials.

Enrollment posture brief

Registry condition partial-epilepsy

OPEN 3 | RECR 38% | LATE 3 | EARLY 0 | RANK #2176 | SPON 5

Volume-matched condition peers

Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)

Activity, Motor75%Achalasia50%Partial Epilepsy (this)38%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Partial Epilepsy

Partial Epilepsy lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Partial Epilepsy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Partial Epilepsy is recruiting below its size-band peers.

    3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Partial Epilepsy research.

    National Institute of Neurological Disorders and Stroke (NINDS) accounts for 5 of 8 trials (62.5%). 3 distinct sponsors appear on at least one study for this condition label.

  3. Typical Partial Epilepsy enrolment sits around 300 participants.

    Median target enrolment is 300 among the 8 trials that report a genuine target (sentinel values excluded). 3 of those (37.5%) plan for fewer than 100 participants.

  4. Partial Epilepsy research leans observational.

    3 interventional and 5 observational studies make up this index (37.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 33

Phase Distribution

PhaseTrial count
Phase 3 3

Top Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) 5 trials
SK Life Science 2 trials
Bial - Portela C S.A. 1 trials

Named interventions

Most-linked intervention names on Partial Epilepsy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

YKP3089 Drug
1 trials
1200 mg QD Eslicarbazepine acetate Drug
1 trials
800 mg QD Eslicarbazepine acetate Drug
1 trials
Magpro High-Speed Magnetoelectric Stimulator Device
1 trials
Cadwell High-Speed Magnetoelectric Stimulator Device
1 trials
18 FDG Drug
1 trials
Xcopri Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Partial Epilepsy trials. A trial with sites in several states counts in each.

Maryland 7 trials
California 3 trials
Arizona 3 trials
Missouri 2 trials
Minnesota 2 trials
Georgia 2 trials
Florida 2 trials
Colorado 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Partial Epilepsy page

8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Partial Epilepsy condition card totals 8 registered trials; most-linked intervention YKP3089; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.